MD
Chief Operations Officer
Get the full picture
Sign in to uncover key details.
Neu Therapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5752 Wildbriar Dr, Rancho Palos Verdes, ...Phone Number
(323) 442-1430Website
www.neutherapeutics.comRevenue
<$5 MillionIndustry
About Neu Therapeutics
NEUTherapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for neurodegenerative diseases, particularly Alzheimer's disease. Their lead product, Allopregnanolone, aims to halt and potentially reverse the progression of Alzheimer's and is currently in Phase 2b clinical trials. Additionally, they offer PhytoSERM, a plant-based supplement designed to alleviate menopausal symptoms while promoting brain health. The company emphasizes a patient-inspired, data-driven approach to precision medicine and is committed to bridging the gap between scientific discovery and effective treatments.Explore more
Neu Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Neu Therapeutics
Compare insights from companies similar to Neu Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Neu Therapeutics Tech Stack
A closer look at the technologies used by Neu Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neu Therapeutics
Sign Up For FreeTo access detailed company insights
NEUTherapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for neurodegenerative diseases, particularly Alzheimer's disease. Their lead product, Allopregnanolone, aims to halt and potentially reverse the progression of Alzheimer's and is currently in Phase 2b clinical trials. Additionally, they offer Phyto... Read More
